Savant Capital LLC Acquires 14,271 Shares of DENTSPLY SIRONA Inc. $XRAY

Savant Capital LLC raised its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 12.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 129,234 shares of the medical instruments supplier’s stock after purchasing an additional 14,271 shares during the quarter. Savant Capital LLC owned approximately 0.06% of DENTSPLY SIRONA worth $2,052,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of XRAY. Vanguard Group Inc. raised its position in shares of DENTSPLY SIRONA by 2.8% in the first quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock valued at $309,864,000 after purchasing an additional 557,329 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in DENTSPLY SIRONA by 11.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock valued at $208,590,000 after acquiring an additional 1,412,517 shares during the period. Fuller & Thaler Asset Management Inc. lifted its position in DENTSPLY SIRONA by 4.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock worth $180,445,000 after acquiring an additional 538,531 shares during the last quarter. AQR Capital Management LLC boosted its holdings in shares of DENTSPLY SIRONA by 119.4% during the first quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock worth $93,423,000 after acquiring an additional 3,453,662 shares during the period. Finally, Edmond DE Rothschild Holding S.A. grew its position in shares of DENTSPLY SIRONA by 26.4% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier’s stock valued at $43,526,000 after purchasing an additional 609,300 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

XRAY has been the subject of several recent research reports. Stifel Nicolaus set a $13.00 price target on DENTSPLY SIRONA in a research note on Thursday, November 6th. Evercore ISI reduced their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research report on Wednesday, October 8th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a research note on Tuesday, October 28th. Finally, JPMorgan Chase & Co. decreased their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. Two equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $16.08.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $10.98 on Wednesday. The firm’s 50 day simple moving average is $12.86 and its 200 day simple moving average is $14.45. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of -2.32, a P/E/G ratio of 0.81 and a beta of 1.00. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA Inc. has a 1 year low of $10.69 and a 1 year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). The business had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.